Skip to main content

Advertisement

Table 1 Characteristics of the 58 STS patients treated with pazopanib

From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

Characteristics No. Percentage
Age
 Median 52  
 Range 19–72  
  ≥ 60 year 19 33
Gender
 Male 28 48
 Female 30 52
ECOG performance status
 0 35 60
 1 23 40
 2 or more 0 0
Smoking history
 Absent 38 66
 Present 20 34
Smoking index
 Median 238  
 Range 64–1170  
  ≥ 400 6 10
Hypertension
 Absent 48 83
 Present 10 17
Pathological diagnoses
 Leiomyosarcoma 13 22
 Synovial sarcoma 9 16
 Liposarcoma 9 16
 Other histologies 27 46
Primary site of disease
 Extremities 21 36
 Non-extremities 37 64
Pulmonary disease
 Lung lesions present 41 71
 Pleural lesions present 23 40
Number of lung lesions
 1 6 10
 2–5 16 28
 6–9 6 10
  > 10 13 22
Maximum diameter of lung lesions
  < 10 mm 2 3
 10–20 mm 11 19
 20–30 mm 7 12
 30–50 mm 8 14
  > 50 mm 13 22